Borneo Journal of Pharmacy最新文献

Pengaruh Program Edukası Hıdup Sehat terhadap Penurunan Berat Badan dan Lıngkar Perut pada Mahasıswa Keperawatan 项目影响EdukasıHı生活健康的减肥和Lıngkar通便作用Mahası上行链路护理

Borneo Journal of Pharmacy Pub Date : 2023-08-31 DOI: 10.57174/j.born.v3i2.99

Haris Haris

{"title":"Pengaruh Program Edukası Hıdup Sehat terhadap Penurunan Berat Badan dan Lıngkar Perut pada Mahasıswa Keperawatan","authors":"Haris Haris","doi":"10.57174/j.born.v3i2.99","DOIUrl":"https://doi.org/10.57174/j.born.v3i2.99","url":null,"abstract":"Kelebihan berat badan menjadi faktor risiko penyakit tidak menular demikian juga dengan lingkar perut. Kedua indikator tersebut banyak dijumpai pada usia produktif termasuk mahasiswa. Pola hidup sehat merupakan kunci untuk mencegah kelebihan berat badan dan lingkar perut. Penelitian ini bertujuan untuk menganilisis pengaruh program edukasi hidup sehat dalam menurunkan berat badan dan lingkat perut. Metode Penelitian yang digunakan adalah quasi experiment without control. Variabel dependen adalah berat badan dan lingkar perut dan variabel independen adalah program hidup sehat. Populasi sasaran adalah seluruh mahasiswa program studi D3 Keperawatan yang berjumlah 93 orang. Teknik pengambilan sampel menggunakan purposive sampling. Kriteria Inklusi adalah mahasiswa atau mahasiswi yang memiliki berat badan lebih dari normal. Sementara kriteria ekslusif adalah mahasiswa yang memiliki riwayat hipertensi atau diabetes mellitus serta mahasiswa yang dalam kondisi sakit saat dilakukan skrening. Data calon responden diperoleh dari skriningpopulasi sasaran dan diseleksi berdasarkan kriteria inklusi. Jumlah sampel sebanyak 28 orang. Di awal pertemuan responden diberikan edukasi selama 60 menit dan diberikan lembaran program hidup sehat yang dijalankan dan dilaporkan setiap hari selama 7 hari. Setelah dilakukan pretest dan post, kedua data diolah dan dilakukan uji normalitas data dan hasilnya > 0,05 yang berarti data distribusi normal. Hasil. Hasil uji t berpasangan, berat badan sebelum dan sesudah program edukasi didapatkan p-value 0,000 sementara lingkar perut sebelum dan sesudah program edukasi didapatkan p-value 0,000. Program pola hidup sehat yang dijalankan secara konsisten terutama dalam pembatasan jumlah makanan tinggi karbohidrat dan lemak serta melakukan aktifitas fisik dapat mengurangi pembentukan lemak tubuh. Kesimpulan. Program edukasi hidup sehat hidup sehat yang dijalankan selama 7 hari memiliki pengaruh terhadap penurunan berat badan dan lingkar perut.","PeriodicalId":9118,"journal":{"name":"Borneo Journal of Pharmacy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76793313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

2D-QSAR, Docking, Molecular Dynamics Simulations with the MM/GBSA Approaches against Graves' Disease and PTPN22 2D-QSAR，对接，分子动力学模拟与MM/GBSA方法对抗Graves病和PTPN22

Borneo Journal of Pharmacy Pub Date : 2023-08-30 DOI: 10.33084/bjop.v6i3.4915

Emmanuel Israel Edache, Adamu Uzairu, Paul Andrew Mamza, Gideon Adamu Shallangwa

{"title":"2D-QSAR, Docking, Molecular Dynamics Simulations with the MM/GBSA Approaches against Graves' Disease and PTPN22","authors":"Emmanuel Israel Edache, Adamu Uzairu, Paul Andrew Mamza, Gideon Adamu Shallangwa","doi":"10.33084/bjop.v6i3.4915","DOIUrl":"https://doi.org/10.33084/bjop.v6i3.4915","url":null,"abstract":"Graves' disease (GD) is an autoimmune condition that frequently causes hyperthyroidism and thyrotoxicosis. Protein tyrosine phosphatase, non-receptor type 22 (lymphoid) isoform 1 (PTPN22), is a promising therapeutic candidate for treating GD, rheumatoid arthritis, type 1 diabetes, and other autoimmune disorders. In this dataset, 31 molecular compounds and two standard drugs were optimized using the semi-empirical PM7 theory method via MOPAC v22.0.4 to reveal the key influencing factors contributing to their grave's disease inhibition activity and selectivity. Using QSARIN software, the acquired properties/descriptors were used to create a quantitative structural activities relationship (QSAR) model, and the similarities between the observed and predicted pIC50 values were examined. A molecular docking simulation study also uncovers non-covalent interactions between the investigated compounds and the receptors. The observed ligand-protein interactions with GD proteins (PDB ID 2XPG and 4QT5) and PTPN22 (PDB ID 3BRH) were investigated. The pharmacokinetics (ADMET) properties were also investigated. Finally, molecular dynamics (MD) simulation and MM/GBSA studies that demonstrated stable trajectory and molecular properties with a consistent interaction profile were used to validate the stability of the compounds in the complex with PTPN22.","PeriodicalId":9118,"journal":{"name":"Borneo Journal of Pharmacy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136242061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Qualitative Evaluation on the Use of Pneumonia Antibiotics for Covid-19 Patients at X Hospital Bali in 2020 巴厘X医院2020年新冠肺炎患者肺炎抗生素使用定性评价

Borneo Journal of Pharmacy Pub Date : 2023-08-30 DOI: 10.33084/bjop.v6i3.2855

Wirda Anggraini, Fitria Rahma Fauzia, Arief Suryadinata, Burhan Ma'arif, Ni Nyoman Sri Budayanti, Fransiska Rosari Dewi

{"title":"Qualitative Evaluation on the Use of Pneumonia Antibiotics for Covid-19 Patients at X Hospital Bali in 2020","authors":"Wirda Anggraini, Fitria Rahma Fauzia, Arief Suryadinata, Burhan Ma'arif, Ni Nyoman Sri Budayanti, Fransiska Rosari Dewi","doi":"10.33084/bjop.v6i3.2855","DOIUrl":"https://doi.org/10.33084/bjop.v6i3.2855","url":null,"abstract":"Coronavirus disease-19 (Covid-19) is a pandemic that has caused various complications, including pneumonia. One of the therapies used in Covid-19 with pneumonia complications is antibiotics. Antibiotics must be used appropriately to prevent antibiotic resistance. A method to reduce the number of antibiotic resistances is evaluating the use of antibiotics qualitatively using the Gyssens method. Therefore, this study aims to describe the profile and rationality of using pneumonia antibiotics for adult Covid-19 patients at X Hospital from January to December 2020. The data was collected retrospectively on adult patients using the patient's medical record data, and the sample was determined using the purposive sampling technique. There were 117 samples of medical record data processed in this study. This study concluded that the use of antibiotics for patients with Covid-19 disease consisted of single antibiotic usage, i.e., azithromycin in 82 cases (70.09%), and levofloxacin in 30 cases (25.64%), and switched antibiotics usage, i.e., azithromycin to levofloxacin in 5 cases (4.27%). The rationality of using antibiotics using the Gyssens methods was 90.60% with rational or appropriate antibiotics use (category 0). Moreover, there was 9.40% irrational drug use (category I-VI), comprising antibiotics for a longer time than it should be, in 11 cases.","PeriodicalId":9118,"journal":{"name":"Borneo Journal of Pharmacy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136242059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Potential Antidiabetic Compounds from Anogeissus leiocarpus: Molecular Docking, Molecular Dynamic Simulation, and ADMET Studies 黑参中潜在的抗糖尿病化合物:分子对接、分子动力学模拟和ADMET研究

Borneo Journal of Pharmacy Pub Date : 2023-08-30 DOI: 10.33084/bjop.v6i3.5027

Mubarak Muhammad Dahiru, Neksumi Musa, AbdulAzeez Mumsiri Abaka, Maimuna Abdulrahman Abubakar

{"title":"Potential Antidiabetic Compounds from Anogeissus leiocarpus: Molecular Docking, Molecular Dynamic Simulation, and ADMET Studies","authors":"Mubarak Muhammad Dahiru, Neksumi Musa, AbdulAzeez Mumsiri Abaka, Maimuna Abdulrahman Abubakar","doi":"10.33084/bjop.v6i3.5027","DOIUrl":"https://doi.org/10.33084/bjop.v6i3.5027","url":null,"abstract":"This study aimed to evaluate the antidiabetic potential of compounds from Anogeissus leiocarpus in silico and the potential of the compounds as antidiabetic drug candidates. Molecular docking (MD), molecular dynamics simulation (MDS), and ADMET were carried out in silico to evaluate the compounds' antidiabetic potential and drug candidacy. The MDS revealed the least BA (-8.7 kcal/mol) was exhibited by compound X (palmitic acid) with Glucagon-like Peptide-1 Receptor (GLP1), while the highest BA (-5.8 kcal/mol) was demonstrated by I (1,2,4-benzetriol) with dipeptidyl peptidase IV (DPP-4) among the best interactions. The MDS result showed good docked complexes' flexibility, deformability, and stability with low eigenvalues ranging from 8.52 × 10-5 to 1.30 × 10-4. All the compounds had a bioavailability score of 0.55 except VI (0.85), while the synthetic ability showed a good score of ≤3.01. Eight compounds were predicted to be soluble, with two poorly soluble. Additionally, all the compounds had high gastrointestinal absorption, with the majority being blood-brain barrier permeant, while skin permeation value was between -2.55 and -7.48 cm/s. Furthermore, none of the compounds were either permeability glycoprotein (P-gp) substrate or CYP2C19 and CYP2C9 inhibitors, though some were CYP1A2, CYP2D6, and CYP3A4 inhibitors. Moreover, the toxicity study showed moderate to non-toxicity results with toxicity classes between 3 and 5. Conclusively, the compounds from A. leiocarpus showed good binding interactions, which are the protein targets of antidiabetic therapy and potentially good candidates for antidiabetic drug development.","PeriodicalId":9118,"journal":{"name":"Borneo Journal of Pharmacy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136242057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Quality of Life in End-Stage Renal Disease Patients Undergoing Hemodialysis and Its Affecting Factors in a Hemodialysis Unit of General Hospital Denpasar 登巴萨总医院血液透析科终末期肾病患者血液透析的生活质量及其影响因素

Borneo Journal of Pharmacy Pub Date : 2023-08-30 DOI: 10.33084/bjop.v6i3.3907

Agustina Nila Yuliawati, Pande Made Desy Ratnasari, Ni Luh Putu Satria Maharani

{"title":"Quality of Life in End-Stage Renal Disease Patients Undergoing Hemodialysis and Its Affecting Factors in a Hemodialysis Unit of General Hospital Denpasar","authors":"Agustina Nila Yuliawati, Pande Made Desy Ratnasari, Ni Luh Putu Satria Maharani","doi":"10.33084/bjop.v6i3.3907","DOIUrl":"https://doi.org/10.33084/bjop.v6i3.3907","url":null,"abstract":"End-stage renal disease (ESRD) patients undergoing hemodialysis (HD) repeatedly can affect their quality of life (QOL). Its QOL value can vary according to the patient's characteristics amid health conditions that may make it difficult for them. This study aimed to analyze the QOL of ESRD patients undergoing HD and its affecting factors. This cross-sectional study was conducted in a Hemodialysis Outpatient Unit of General Hospital, Denpasar, Bali, from April to May 2021. A sample of 103 respondents was obtained by using the purposive sampling technique. Inclusion criteria were ESRD patients undergoing HD aged ≥8 years old, completing questionnaires thoroughly, and communicating well. Data was collected through the KDQOL-36 questionnaire to measure the QOL and medical records for completeness of patient identities. Data were analyzed using Spearman's ρ, η, Mann-Whitney, and an Independent sample t-test (CI 95%). Findings showed the majority of respondents were aged <60 years (75.7%), had secondary education (41.7%), were working (50.5%), were diagnosed with ESRD, and undergoing HD <3 Years (81.6%), the duration of each HD >4 hours (85.4%), three times a week (91.3%), having a BMI >29 kg/m2 (89.3%), and hypertension (42.7%). The respondents experienced major problems in their QOL on the burden of ESRD (33.50±24.64), physical (39.57±8.94), and mental component summary (52.62±10.39) dimensions. Respondent's characteristics, including education level, duration of each HD, and diagnosis with ESRD undergoing HD, contributed to their QOL (p <0.05). The patient's QOL needs to be improved through the family and health worker's support.","PeriodicalId":9118,"journal":{"name":"Borneo Journal of Pharmacy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136242058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Fibrinolytic Protease Activity of Crude Enzyme from Fermented Sunflower (Helianthus annuus) and Common Bean (Phaseolus vulgaris) seeds by Rhizopus microsporus var. oligosporus FNCC 6010 in Solid State Fermentation 小孢子根霉var. oligosporus FNCC 6010固态发酵向日葵(Helianthus annuus)和菜豆(Phaseolus vulgaris)种子粗酶活性的研究

Borneo Journal of Pharmacy Pub Date : 2023-08-30 DOI: 10.33084/bjop.v6i3.4665

Rebhika Lusiana, Achmad Toto Poernomo, Achmad Syahrani

{"title":"Fibrinolytic Protease Activity of Crude Enzyme from Fermented Sunflower (Helianthus annuus) and Common Bean (Phaseolus vulgaris) seeds by Rhizopus microsporus var. oligosporus FNCC 6010 in Solid State Fermentation","authors":"Rebhika Lusiana, Achmad Toto Poernomo, Achmad Syahrani","doi":"10.33084/bjop.v6i3.4665","DOIUrl":"https://doi.org/10.33084/bjop.v6i3.4665","url":null,"abstract":"In the entire world, cardiovascular diseases (CVDs) are the main cause of death. For the treatment of CVDs, microbial fibrinolytic enzymes are highly regarded as novel therapeutic candidates. This study was purposed to determine the fibrinolytic protease activity produced by fungus source, which is Rhizopus microsporus var. oligosporus FNCC 6010 in fermented sunflower (Helianthus annuus) seed and common bean (Phaseolus vulgaris) seed. Fermentation was carried out by solid-state fermentation method at an initial pH of 5, incubation temperature of 33±1°C, and incubation time of 24 hours. The fermented seed was extracted to obtain supernatant as the crude enzyme. The proteolytic activity assay was done by the skimmed milk agar (SMA) plate method to obtain the proteolytic index, and the fibrinolytic activity assay was conducted by the fibrin-agarose plate method to get the fibrinolytic index. The results show that crude enzymes from fermented H. annuus and P. vulgaris seeds by R. microsporus have fibrinolytic protease activity with proteolytic index 2.64 ± 0.01 and 2.23 ± 0.04, respectively. The fibrinolytic index is 2.40 ± 0.06 and 1.64 ± 0.06, respectively. Therefore, the crude enzyme has the potential to be further researched as a candidate for thrombolytic agents. The purification, characterization, and in-depth research are needed to develop enzymes into preparations for preventing and treating CVDs.","PeriodicalId":9118,"journal":{"name":"Borneo Journal of Pharmacy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136242063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Utilization, Phytochemistry and Biological Activity of Hua gabonii Pierre ex De Wild. 花椒的利用、植物化学及生物活性研究。

Borneo Journal of Pharmacy Pub Date : 2023-08-30 DOI: 10.33084/bjop.v6i3.4239

Clément Mutunda Mbadiko, Gédéon Ngiala Bongo, Jean-Paul Koto-te-Nyiwa Ngbolua, Marie Claire Dembo D’A Letshu Yandju, Pius Tshimankinda Mpiana, Théophile Fundu Mbemba

引用次数: 0

Aloe vera Gel Ameliorates Fat-Rich and High Fructose (FRHF) Diet-Induced Pancreatic and Splenic Damage in Mice 芦荟凝胶改善富含脂肪和高果糖(FRHF)饮食引起的小鼠胰腺和脾脏损伤

Borneo Journal of Pharmacy Pub Date : 2023-08-30 DOI: 10.33084/bjop.v6i3.5351

Nathan Isaac Dibal, Zainab Muhammad Goni, Martha Orendu Oche Attah, Umar Imam, Muhammad Abdullahi, Muzammil Bashir, Usman Adam, Fatima Aisami, Mohammed Shuwa, Sunday Joseph Manye, Madu Nom Gadzama, Musa Samaila Chiroma, Helga Bedan Ishaya

{"title":"Aloe vera Gel Ameliorates Fat-Rich and High Fructose (FRHF) Diet-Induced Pancreatic and Splenic Damage in Mice","authors":"Nathan Isaac Dibal, Zainab Muhammad Goni, Martha Orendu Oche Attah, Umar Imam, Muhammad Abdullahi, Muzammil Bashir, Usman Adam, Fatima Aisami, Mohammed Shuwa, Sunday Joseph Manye, Madu Nom Gadzama, Musa Samaila Chiroma, Helga Bedan Ishaya","doi":"10.33084/bjop.v6i3.5351","DOIUrl":"https://doi.org/10.33084/bjop.v6i3.5351","url":null,"abstract":"High-fat diet alone or in combination with high fructose has been known to induce diabetes, obesity, hypertension, and immune dysfunction. The study evaluates the role of Aloe vera in fat-rich and high fructose diet-induced (FRHFD) hyperglycemias in addition to testicular and splenic morphology in mice. Twenty BALB/c Mice were randomly distributed into four groups (n=5). The groups were fed on a normal diet, FRHFD, FRHFD + 10 g A. vera, and FRHFD + 20 g A. vera for 10 weeks. All the mice were sacrificed a day after the 10 weeks of treatment. The result showed that mice fed on FRHFD plus A. vera had a significantly lower (p<0.05) blood glucose level relative to the FRHFD-fed mice. The mice fed on FRHFD plus A. vera had a significantly lower (p<0.05) blood glucose level relative to the FRHFD-fed mice. Aloe vera was found to ameliorate FRHFD-induced pancreatic islet and acini damage. It also prevented distorted lymphoid cells and testicular damage induced by FRHFD. Aloe vera prevents hyperglycemia and protects pancreatic islets in FRHFD-fed mice. It further prevents immune dysfunction and protects against testicular damage. Hence, A. vera supplementation could be an alternative and/or complementary therapy for hyperglycemia-related disorders.","PeriodicalId":9118,"journal":{"name":"Borneo Journal of Pharmacy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136242072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Characterization of Secondary Metabolites Profile from Methanol Fraction of Temurui (Murraya koenigii (Linn.) Spreng) Leaves Using UPLC-MS Temurui (Murraya koenigii (Linn.))甲醇馏分次生代谢物谱的表征使用UPLC-MS分析春季叶片

Borneo Journal of Pharmacy Pub Date : 2023-08-30 DOI: 10.33084/bjop.v6i3.4662

Intania Permata, Adlis Santoni, Afrizal Afrizal, Trisno Afandi

引用次数: 0

Cover, Content, and Editorial Note from Borneo J Pharm Vol. 6 No. 3 August 2023 封面、内容和编辑注释来自Borneo J Pharm第6卷第3期，2023年8月

Borneo Journal of Pharmacy Pub Date : 2023-08-30 DOI: 10.33084/bjop.v6i3.6067

Chief Editor of Borneo J Pharm

{"title":"Cover, Content, and Editorial Note from Borneo J Pharm Vol. 6 No. 3 August 2023","authors":"Chief Editor of Borneo J Pharm","doi":"10.33084/bjop.v6i3.6067","DOIUrl":"https://doi.org/10.33084/bjop.v6i3.6067","url":null,"abstract":"Assalamu’alaikum Wr. Wb. Alhamdulillahirabbil ‘alamin. The next edition of Borneo Journal of Pharmacy (Borneo J Pharm), has been published at August 2023. This edition contains ten articles: Pharmacology-Toxicology, Analytical Pharmacy-Medicinal Chemistry, Natural Product Development, Microbiology Pharmacy, and Clinical-Community Pharmacy. This edition includes writings from five countries: Cyprus, Indonesia, Malaysia, Nigeria, and the Democratic Republic of the Congo. The authors come from several institutions, including University of Maiduguri, Cyprus International University, Newcastle University Medicine Malaysia, Ahmadu Bello University, Adamawa State Polytechnic, Modibbo Adama University, Politeknik ATI Padang, Universitas Andalas, Politeknik Teknologi Kimia Industri Medan, Université de Kinshasa, Universitas Airlangga, Universitas Ahmad Dahlan, Universitas Islam Negeri Maulana Malik Ibrahim, Universitas Udayana, Institut Teknologi dan Kesehatan Bali, Sekolah Tinggi Farmasi Mahaganesha, and Universitas Gadjah Mada. Editorial boards are fully aware that there are still room for improvement in this edition, hence with all humility willing to accept constructive suggestions and feedback for improvements to the publication for the next editions. The editorial board would like to thank all editors and reviewers, and contributors of the scientific articles who have provided the repetoire in this issue. We hope that all parties, especially the contributors, could re-participate for the publication in the next edition on November 2023. Wassalamu’alaikum Wr. Wb.","PeriodicalId":9118,"journal":{"name":"Borneo Journal of Pharmacy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136242060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0